Annual CFO
-$124.82 M
-$14.76 M-13.41%
December 31, 2023
Summary
- As of February 6, 2025, KURA annual cash flow from operations is -$124.82 million, with the most recent change of -$14.76 million (-13.41%) on December 31, 2023.
- During the last 3 years, KURA annual CFO has fallen by -$54.99 million (-78.75%).
- KURA annual CFO is now -596.37% below its all-time high of -$17.93 million, reached on December 31, 2015.
Performance
KURA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$43.44 M
-$910.00 K-2.14%
September 30, 2024
Summary
- As of February 6, 2025, KURA quarterly cash flow from operations is -$43.44 million, with the most recent change of -$910.00 thousand (-2.14%) on September 30, 2024.
- Over the past year, KURA quarterly CFO has dropped by -$9.13 million (-26.62%).
- KURA quarterly CFO is now -1053.17% below its all-time high of -$3.77 million, reached on June 30, 2015.
Performance
KURA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$169.12 M
-$14.41 M-9.32%
September 30, 2024
Summary
- As of February 6, 2025, KURA TTM cash flow from operations is -$169.12 million, with the most recent change of -$14.41 million (-9.32%) on September 30, 2024.
- Over the past year, KURA TTM CFO has dropped by -$44.30 million (-35.49%).
- KURA TTM CFO is now -4001.92% below its all-time high of -$4.12 million, reached on March 31, 2015.
Performance
KURA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KURA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.4% | -26.6% | -35.5% |
| 3 y3 years | -78.8% | -26.6% | -35.5% |
| 5 y5 years | -156.6% | -26.6% | -35.5% |
KURA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -19.4% | at low | -106.8% | +11.1% | -61.8% | at low |
| 5 y | 5-year | -128.0% | at low | -211.8% | +11.1% | -208.8% | at low |
| alltime | all time | -596.4% | at low | -1053.2% | +11.1% | -4001.9% | at low |
Kura Oncology Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$43.44 M(+2.1%) | -$169.12 M(+9.3%) |
| Jun 2024 | - | -$42.53 M(-12.9%) | -$154.71 M(+12.3%) |
| Mar 2024 | - | -$48.84 M(+42.4%) | -$137.80 M(+10.4%) |
| Dec 2023 | -$124.82 M(+13.4%) | -$34.31 M(+18.2%) | -$124.82 M(+6.6%) |
| Sep 2023 | - | -$29.03 M(+13.3%) | -$117.05 M(+7.4%) |
| Jun 2023 | - | -$25.62 M(-28.6%) | -$109.03 M(-4.2%) |
| Mar 2023 | - | -$35.87 M(+35.2%) | -$113.75 M(+3.4%) |
| Dec 2022 | -$110.06 M(+5.3%) | -$26.53 M(+26.3%) | -$110.06 M(+3.0%) |
| Sep 2022 | - | -$21.01 M(-30.8%) | -$106.90 M(-3.2%) |
| Jun 2022 | - | -$30.34 M(-5.7%) | -$110.48 M(+2.1%) |
| Mar 2022 | - | -$32.18 M(+37.7%) | -$108.22 M(+3.5%) |
| Dec 2021 | -$104.55 M(+49.7%) | -$23.37 M(-5.0%) | -$104.55 M(+5.1%) |
| Sep 2021 | - | -$24.59 M(-12.4%) | -$99.49 M(+8.3%) |
| Jun 2021 | - | -$28.07 M(-1.6%) | -$91.86 M(+17.0%) |
| Mar 2021 | - | -$28.52 M(+55.8%) | -$78.53 M(+12.5%) |
| Dec 2020 | -$69.83 M(+27.5%) | -$18.31 M(+7.9%) | -$69.83 M(+6.7%) |
| Sep 2020 | - | -$16.97 M(+15.1%) | -$65.45 M(+8.0%) |
| Jun 2020 | - | -$14.73 M(-25.7%) | -$60.63 M(+0.5%) |
| Mar 2020 | - | -$19.82 M(+42.3%) | -$60.33 M(+10.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$54.76 M(+12.5%) | -$13.93 M(+14.7%) | -$54.76 M(+7.3%) |
| Sep 2019 | - | -$12.14 M(-15.8%) | -$51.04 M(-1.6%) |
| Jun 2019 | - | -$14.43 M(+1.3%) | -$51.89 M(+3.7%) |
| Mar 2019 | - | -$14.25 M(+39.6%) | -$50.05 M(+2.9%) |
| Dec 2018 | -$48.66 M(+71.1%) | -$10.21 M(-21.5%) | -$48.66 M(+6.0%) |
| Sep 2018 | - | -$13.00 M(+3.2%) | -$45.92 M(+17.3%) |
| Jun 2018 | - | -$12.59 M(-2.0%) | -$39.15 M(+19.8%) |
| Mar 2018 | - | -$12.85 M(+71.9%) | -$32.67 M(+14.9%) |
| Dec 2017 | -$28.44 M(+12.2%) | -$7.47 M(+19.9%) | -$28.44 M(+2.7%) |
| Sep 2017 | - | -$6.24 M(+2.0%) | -$27.70 M(+2.8%) |
| Jun 2017 | - | -$6.11 M(-29.1%) | -$26.94 M(+1.1%) |
| Mar 2017 | - | -$8.62 M(+28.0%) | -$26.66 M(+5.2%) |
| Dec 2016 | -$25.35 M(+41.4%) | -$6.74 M(+23.1%) | -$25.35 M(+4.7%) |
| Sep 2016 | - | -$5.47 M(-6.1%) | -$24.22 M(+4.5%) |
| Jun 2016 | - | -$5.83 M(-20.4%) | -$23.17 M(+9.7%) |
| Mar 2016 | - | -$7.31 M(+30.5%) | -$21.12 M(+17.8%) |
| Dec 2015 | -$17.93 M | -$5.61 M(+26.5%) | -$17.93 M(+45.5%) |
| Sep 2015 | - | -$4.43 M(+17.6%) | -$12.32 M(+56.1%) |
| Jun 2015 | - | -$3.77 M(-8.6%) | -$7.89 M(+91.4%) |
| Mar 2015 | - | -$4.12 M | -$4.12 M |
FAQ
- What is Kura Oncology annual cash flow from operations?
- What is the all time high annual CFO for Kura Oncology?
- What is Kura Oncology annual CFO year-on-year change?
- What is Kura Oncology quarterly cash flow from operations?
- What is the all time high quarterly CFO for Kura Oncology?
- What is Kura Oncology quarterly CFO year-on-year change?
- What is Kura Oncology TTM cash flow from operations?
- What is the all time high TTM CFO for Kura Oncology?
- What is Kura Oncology TTM CFO year-on-year change?
What is Kura Oncology annual cash flow from operations?
The current annual CFO of KURA is -$124.82 M
What is the all time high annual CFO for Kura Oncology?
Kura Oncology all-time high annual cash flow from operations is -$17.93 M
What is Kura Oncology annual CFO year-on-year change?
Over the past year, KURA annual cash flow from operations has changed by -$14.76 M (-13.41%)
What is Kura Oncology quarterly cash flow from operations?
The current quarterly CFO of KURA is -$43.44 M
What is the all time high quarterly CFO for Kura Oncology?
Kura Oncology all-time high quarterly cash flow from operations is -$3.77 M
What is Kura Oncology quarterly CFO year-on-year change?
Over the past year, KURA quarterly cash flow from operations has changed by -$9.13 M (-26.62%)
What is Kura Oncology TTM cash flow from operations?
The current TTM CFO of KURA is -$169.12 M
What is the all time high TTM CFO for Kura Oncology?
Kura Oncology all-time high TTM cash flow from operations is -$4.12 M
What is Kura Oncology TTM CFO year-on-year change?
Over the past year, KURA TTM cash flow from operations has changed by -$44.30 M (-35.49%)